RJA
PROF

Raymond James & Associates’s Profound Medical PROF Stock Holding History

Raymond James & Associates’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$342K Buy
43,005
+4,090
+11% +$37K ﹤0.01% 3333
2024
Q2 		$326K Sell
38,915
-11,065
-22% -$89.2K ﹤0.01% 3328
2024
Q1 		$426K Sell
49,980
-15,713
-24% -$131K ﹤0.01% 3158
2023
Q4 		$558K Sell
65,693
-2,038
-3% -$19.4K ﹤0.01% 2892
2023
Q3 		$691K Buy
67,731
+5,125
+8% +$53.1K ﹤0.01% 2684
2023
Q2 		$815K Buy
62,606
+3,945
+7% +$48.9K ﹤0.01% 2605
2023
Q1 		$545K Sell
58,661
-34,691
-37% -$401K ﹤0.01% 2871
2022
Q4 		$1.02M Buy
93,352
+38,741
+71% +$211K ﹤0.01% 2427
2022
Q3 		$221K Sell
54,611
-6,870
-11% -$46.4K ﹤0.01% 3388
2022
Q2 		$448K Buy
61,481
+835
+1% +$6.6K ﹤0.01% 2985
2022
Q1 		$546K Sell
60,646
-13,281
-18% -$128K ﹤0.01% 3019
2021
Q4 		$834K Buy
73,927
+8,231
+13% +$103K ﹤0.01% 2745
2021
Q3 		$958K Buy
65,696
+11,136
+20% +$170K ﹤0.01% 2609
2021
Q2 		$888K Buy
54,560
+19,054
+54% +$354K ﹤0.01% 2670
2021
Q1 		$712K Buy
35,506
+14,066
+66% +$337K ﹤0.01% 2748
2020
Q4 		$441K Sell
21,440
-1,981
-8% -$36.4K ﹤0.01% 2896
2020
Q3 		$412K Buy
+23,421
New +$372K ﹤0.01% 2763
2020
Q2 		– Sell
-10,400
Closed -$100K – 3631
2020
Q1 		$100K Buy
+10,400
New +$135K ﹤0.01% 3218

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Raymond James & Associates's PROF Position: Q3 2024 in Review

Raymond James & Associates increased its Profound Medical (PROF) stake by 11% in Q3 2024, buying an estimated $37K and bringing the position to 43,005 shares worth $342K. The position accounts for ﹤0.01% of the portfolio, ranked #3333.

Raymond James & Associates first reported a position in PROF in Q1 2020 and has held it in 18 quarters since. The position peaked at $1.02M in Q4 2022. 44 funds tracked by Wall St. Rank hold PROF as of Q3 2024.

  • Raymond James & Associates held 43,005 shares of Profound Medical worth $342K as of Q3 2024.
  • Raymond James & Associates bought 4,090 Profound Medical shares in Q3 2024, an estimated $37K.
  • Profound Medical made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3333 holding.
  • Raymond James & Associates first reported a position in Profound Medical in Q1 2020 and has held it in 18 quarters since.
  • Raymond James & Associates's Profound Medical position peaked at $1.02M in Q4 2022.
  • 44 funds tracked by Wall St. Rank held Profound Medical as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.